U.S. Construction Stock News

Iowa Attorney General Brenna Bird has sued General Motors and its OnStar unit, alleging they collected and sold detailed driving data from Iowans without consent since 2015, in violation of the Iowa Consumer Fraud Act. The case spotlights how GM’s push to monetize connected-vehicle data through services like OnStar can collide with evolving expectations around privacy and transparency. We’ll now examine how this alleged misuse of OnStar driving data could affect GM’s investment narrative...

If you are looking at NovoCure and wondering whether the recent share price makes sense, this article will walk through what that price might be implying about the stock's value. The shares last closed at US$13.67, with returns of 20.3% over the past 7 days and 10.2% over 30 days, set against a 4.2% return year to date and a 28.3% decline over 1 year, and an 82.5% and 89.4% decline over 3 and 5 years respectively. Recent news coverage around NovoCure has focused on the company as a Nasdaq...

Broadcom (NasdaqGS:AVGO) has begun shipping what it describes as the industry's first 2nm custom compute SoC using 3.5D XDSiP stacking technology. The chip is being rolled out with Fujitsu, targeting power efficient, high performance AI compute for next generation data center clusters. Early use cases focus on AI and data center workloads where power efficiency and compute density are critical. For investors watching Broadcom at a current share price of $319.55, this launch adds a fresh...

ZoomInfo Technologies (GTM) moved back into focus after Nvidia CEO Jensen Huang argued that artificial intelligence is more likely to support, not threaten, enterprise software providers such as ZoomInfo. See our latest analysis for ZoomInfo Technologies. Even after reacting positively to Jensen Huang’s comments, ZoomInfo’s share price remains under pressure, with a 30 day share price return of 22.86% and a 1 year total shareholder return of 46.74%. This indicates that recent momentum has...

In February 2026, Armstrong World Industries reported Q4 2025 results showing higher year-on-year sales and earnings, but both revenue and EPS came in below analyst expectations, and the company issued 2026 earnings guidance that was softer than the market had anticipated. At the same time, Armstrong outlined 2026 targets for net sales of US$1.75–US$1.79 billion and net earnings of US$340–US$349 million, giving investors clearer insight into how management sees demand, margins, and capital...

Carnival Corporation & (CCL) is back in focus after rolling out its fleetwide Carnival Millions digital lottery, while simultaneously rerouting ships away from Puerto Vallarta and canceling some Mexico excursions in response to cartel related violence. See our latest analysis for Carnival Corporation &. Recent news on Carnival Millions and route adjustments sits against a share price of US$31.55, with a 30 day share price return of 5.1% and a 90 day share price return of 21.7%. The 1 year...

If you are wondering whether Qnity Electronics at around US$126.76 is still a fair deal or already priced for perfection, you are in the right place. The stock has been active recently, with returns of 11.7% over 7 days, 31.8% over 30 days and 49.2% year to date, which can change how the market is thinking about both its potential and its risks. Recent coverage of Qnity Electronics has focused on its position within the semiconductor space and how investors are reacting to its current...

Amazon.com (NasdaqGS:AMZN) announced a multi year partnership with OpenAI that includes a $50b investment. As part of the deal, Amazon becomes OpenAI's exclusive third party cloud provider for enterprise hosting. The companies plan to co develop advanced AI platforms and stateful AI environments for business customers. NasdaqGS:AMZN shares last closed at $210.0, with the stock showing a 121.3% gain over the past 3 years and a 40.0% gain over 5 years. More recently, returns have been weaker,...

Micron Technology (NasdaqGS:MU) has opened a new semiconductor assembly and test facility in Sanand, Gujarat, India. This is Micron's first plant of its kind in India and expands its global manufacturing footprint. The company plans for the site to ramp output to tens of millions of chips in 2026 and hundreds of millions in 2027. The facility is intended to support global memory supply as demand from AI infrastructure continues to grow. For you as an investor, this new Sanand plant is about...

If you are looking at Targa Resources and wondering whether the current share price still makes sense, you are not alone. The stock last closed at US$235.80, with returns of 1.9% over 7 days, 17.3% over 30 days, 26.3% year to date and 19.6% over 1 year, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Targa Resources has focused on its position in the energy infrastructure space and how investor sentiment has been reflecting that...

If you are wondering whether Recursion Pharmaceuticals' current share price makes sense, the key question is how that price compares with what the business could reasonably be worth. The stock last closed at US$3.67, with a 7 day return of 7.3%, a 30 day return decline of 12.4%, a year to date return decline of 12.6%, and a 1 year return decline of 51.1%. These figures will shape how many investors think about its potential and risk today. Recent coverage has focused on Recursion...

GoodRx Holdings recently reported fourth-quarter 2025 results, issued 2026 revenue guidance of US$750 million to US$780 million, updated progress on its share buyback, filed a US$74.72 million shelf registration for an ESOP-related Class A stock offering, and disclosed several analyst rating changes. The company also launched GoodRx Employer Direct, a new program that lets employers directly subsidize high-cost drugs like GLP-1s at the pharmacy counter, potentially widening GoodRx’s role in...

Without a clear single event driving headlines, Stellar Bancorp (STEL) is drawing attention as investors weigh its recent share performance, current valuation signals, and the bank’s underlying earnings and revenue profile. See our latest analysis for Stellar Bancorp. At a share price of $37.66, Stellar Bancorp has seen a 22.43% year to date share price return and a 32.00% total shareholder return over the past year, with recent weekly softness tempering the strong 90 day share price momentum...

National HealthCare Corporation reported past fourth-quarter 2025 revenue of US$386.51 million and net income of US$24.85 million, with full‑year 2025 revenue of US$1.52 billion and net income of US$120.02 million, all higher than the prior year. The company highlighted that growth was supported both by higher same‑facility revenues and the contribution from its White Oak Manor acquisition, underscoring the role of expansion alongside core operations in its 2025 results. With this backdrop...

Construction Partners (ROAD) has caught investor attention after its share price moved in recent trading, with recent returns over the past month and past 3 months putting its performance firmly under the spotlight. See our latest analysis for Construction Partners. That near term move sits on top of a much stronger run, with a 22.29% 1 month share price return and a 24.22% 3 month share price return feeding into a 1 year total shareholder return of 85.18%, which suggests momentum has been...

In February 2026, Global-E Online Ltd. reported fourth-quarter 2025 sales of US$336.66 million and net income of US$62.45 million, issued full-year 2026 revenue guidance of US$1.21–US$1.27 billion, and confirmed completion of a US$72 million share repurchase covering 1,938,665 shares. The combination of stronger profitability, higher revenue guidance, and a completed buyback program highlights management’s confidence in Global-E Online’s financial position and growth plans. Next, we’ll...

In February 2026, Six Flags Entertainment reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of US$116.97 million and a quarterly net loss of US$92.38 million, while full-year revenue reached US$3.10 billion with a much larger full-year net loss of US$1.60 billion. The earnings release, combined with Broyhill Asset Management’s exit after citing integration challenges, weather exposure, pressure on lower-income guests, and leadership changes, has sharpened...

Recent commentary on Alexander's (ALX) argues that its vacant retail space is part of a plan to unlock value, not lasting damage, with a refinancing improving liquidity and supporting ongoing dividend payments. See our latest analysis for Alexander's. At a share price of $234.62, Alexander's has seen a 9.86% 90 day share price return and a 7.20% year to date share price return, while the 1 year total shareholder return sits at 18.67%, which reflects recent performance across different time...

In February 2026, Centuri Holdings reported fourth-quarter 2025 results showing revenue of US$858.6 million and net income of US$30.18 million, contributing to full-year revenue of US$2.98 billion and net income of US$22.4 million, alongside issuing 2026 revenue guidance of US$3.24 billion to US$3.54 billion. Management also highlighted a backlog of about US$5.9 billion and a roughly US$13 billion bidding pipeline, indicating substantial contracted and potential work already identified for...

GXO Logistics, Inc. announced that it successfully launched a multi-year partnership with lingerie retailer Hunkemöller, taking over its B2B logistics operations in Almere from January 1, 2026, using a 32,000-square-meter, highly automated site to support pan-European distribution. This is Hunkemöller’s first move to outsource B2B logistics, underscoring GXO’s role as a technology-led logistics partner integrating robotics and shuttle systems into a single, large-scale European hub. Next,...

Why Pacira BioSciences is on investors’ radar today Pacira BioSciences (PCRX) has been drawing attention after a mixed share price pattern, with a 6.7% gain over the past month contrasting with negative returns over the past 3 months and year to date. See our latest analysis for Pacira BioSciences. At the current share price of $21.91, Pacira BioSciences shows a mixed picture, with a 6.7% 30 day share price return set against a 10.4% year to date share price decline and a 68.3% five year...

With no fresh headline driving Inter & Co (NasdaqGS:INTR) today, recent performance and fundamentals come into focus as investors weigh its returns profile against revenue of R$5,984.585 and net income of R$1,312.39. See our latest analysis for Inter & Co. Inter & Co’s share price has eased in the short term, with a 7 day share price return of 5.84% and 30 day share price return of 6.65%, yet its 1 year total shareholder return of 64.56% and 3 year total shareholder return of almost 4x...

Graham Holdings Company recently reported past fourth-quarter and full-year 2025 results showing slightly higher sales but much lower net income and earnings per share, alongside US$10,100,000 of impairment charges, compared with higher impairments and far higher profit a year earlier. Despite the profit drop, the company affirmed a regular quarterly dividend of US$1.88 per share and highlighted operational progress in education and healthcare businesses. We’ll now look at how the sharp...

Astec Industries stock: recent performance in focus Astec Industries (ASTE) has drawn interest after a strong run, with total return figures of 27% over the past month and 42% over the past 3 months. This has put recent price action front and center for investors. See our latest analysis for Astec Industries. The latest share price of US$62.09 sits alongside a 30 day share price return of 27.44% and a 1 year total shareholder return of 76.73%. This signals strong recent momentum following a...